chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine increased, Blood glucose normal, Blood sodium decreased, Blood urea increased, COVID-19
Clinical narrative: Moderna Dose 1 4/27/21 (008C21A); Moderna Dose 2 5/25/21 (024C21A); COVID Positive 1/26/22; 1/26/22: Patient is a 76-year-old male with a past medical history significant for type 2 diabetes with diabetic neuropathy, coronary artery disease, hypertension, peripheral vascular disease, CKD, history of tracheostomy. The patient presents to the ED today via EMS with new onset confusion that began this afternoon. The patient's accompanying symptoms include shortness of breath, and cough.  He denies any chest pain, nausea, vomiting, diarrhea or abdominal pain. The patient tested positive for COVID-19 yesterday at the facility.  The patient was on 3 L oxygen via nasal cannula with O2 saturations at 75% prior to arrival to ED.  since arrival patient's O2 saturations have improved to 92% on 2 L oxygen via nasal cannula.  The patient is vaccinated against COVID-19 and has received is booster vaccination as well. The patient's symptoms began 2 days ago and have worsened rapidly according to the nursing home.  He has not been taking any medications for relief of his symptoms.  The patient denies any alcohol abuse, illicit drug abuse or tobacco use. Upon arrival to ED patient's temperature is 99.3°, heart rate 106, respirations 20, pulse ox 99% on 2 L oxygen via nasal cannula, blood pressure 123/100. Patient's laboratory findings are significant for sodium 132, chloride 95, glucose 184, BUN 63, creatinine 2.73, proBNP 21134, troponin 4.22, WBC 11.81, hemoglobin 11.2, hematocrit 37.6. The patient was started on a heparin drip in the ED and received 750 mg IV Levaquin and 1 L IV normal saline. The patient was seen and examined at the bedside in the ED.  The patient is not oriented x4 per his baseline; however, he is able to answer some questions appropriately. I did have a discussion with the patient and the patient's wife over the phone in regards to his code status.  The patient does have a DNR/DNI with comfort measures only. The patient's wife states that he does not want any procedures done at all as these are his wishes. The patient is being admitted to the hospital for management of COVID-19 pneumonia, NSTEMI, Rule out PE, and dehydration. 1/31/22: Patient is a 76-year-old male history of chronic hypoxic respiratory failure on home oxygen 3 L at baseline admitted to hospital for acute hypoxic respiratory failure due to COVID-19 pneumonia patient was treated with supplemental oxygen, antibiotics and Decadron, hospitalization was complicated by acute kidney injury on CKD and elevated troponin, as time progressed patient improved with medical treatment, patient was evaluated by Cardiology, recommended medical therapy.  Patient will be discharged.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chronic kidney disease, Condition aggravated, Confusional state, Cough
Clinical narrative: Moderna Dose 1 4/27/21 (008C21A); Moderna Dose 2 5/25/21 (024C21A); COVID Positive 1/26/22; 1/26/22: Patient is a 76-year-old male with a past medical history significant for type 2 diabetes with diabetic neuropathy, coronary artery disease, hypertension, peripheral vascular disease, CKD, history of tracheostomy. The patient presents to the ED today via EMS with new onset confusion that began this afternoon. The patient's accompanying symptoms include shortness of breath, and cough.  He denies any chest pain, nausea, vomiting, diarrhea or abdominal pain. The patient tested positive for COVID-19 yesterday at the facility.  The patient was on 3 L oxygen via nasal cannula with O2 saturations at 75% prior to arrival to ED.  since arrival patient's O2 saturations have improved to 92% on 2 L oxygen via nasal cannula.  The patient is vaccinated against COVID-19 and has received is booster vaccination as well. The patient's symptoms began 2 days ago and have worsened rapidly according to the nursing home.  He has not been taking any medications for relief of his symptoms.  The patient denies any alcohol abuse, illicit drug abuse or tobacco use. Upon arrival to ED patient's temperature is 99.3°, heart rate 106, respirations 20, pulse ox 99% on 2 L oxygen via nasal cannula, blood pressure 123/100. Patient's laboratory findings are significant for sodium 132, chloride 95, glucose 184, BUN 63, creatinine 2.73, proBNP 21134, troponin 4.22, WBC 11.81, hemoglobin 11.2, hematocrit 37.6. The patient was started on a heparin drip in the ED and received 750 mg IV Levaquin and 1 L IV normal saline. The patient was seen and examined at the bedside in the ED.  The patient is not oriented x4 per his baseline; however, he is able to answer some questions appropriately. I did have a discussion with the patient and the patient's wife over the phone in regards to his code status.  The patient does have a DNR/DNI with comfort measures only. The patient's wife states that he does not want any procedures done at all as these are his wishes. The patient is being admitted to the hospital for management of COVID-19 pneumonia, NSTEMI, Rule out PE, and dehydration. 1/31/22: Patient is a 76-year-old male history of chronic hypoxic respiratory failure on home oxygen 3 L at baseline admitted to hospital for acute hypoxic respiratory failure due to COVID-19 pneumonia patient was treated with supplemental oxygen, antibiotics and Decadron, hospitalization was complicated by acute kidney injury on CKD and elevated troponin, as time progressed patient improved with medical treatment, patient was evaluated by Cardiology, recommended medical therapy.  Patient will be discharged.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dehydration, Disorientation, Dyspnoea, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: Moderna Dose 1 4/27/21 (008C21A); Moderna Dose 2 5/25/21 (024C21A); COVID Positive 1/26/22; 1/26/22: Patient is a 76-year-old male with a past medical history significant for type 2 diabetes with diabetic neuropathy, coronary artery disease, hypertension, peripheral vascular disease, CKD, history of tracheostomy. The patient presents to the ED today via EMS with new onset confusion that began this afternoon. The patient's accompanying symptoms include shortness of breath, and cough.  He denies any chest pain, nausea, vomiting, diarrhea or abdominal pain. The patient tested positive for COVID-19 yesterday at the facility.  The patient was on 3 L oxygen via nasal cannula with O2 saturations at 75% prior to arrival to ED.  since arrival patient's O2 saturations have improved to 92% on 2 L oxygen via nasal cannula.  The patient is vaccinated against COVID-19 and has received is booster vaccination as well. The patient's symptoms began 2 days ago and have worsened rapidly according to the nursing home.  He has not been taking any medications for relief of his symptoms.  The patient denies any alcohol abuse, illicit drug abuse or tobacco use. Upon arrival to ED patient's temperature is 99.3°, heart rate 106, respirations 20, pulse ox 99% on 2 L oxygen via nasal cannula, blood pressure 123/100. Patient's laboratory findings are significant for sodium 132, chloride 95, glucose 184, BUN 63, creatinine 2.73, proBNP 21134, troponin 4.22, WBC 11.81, hemoglobin 11.2, hematocrit 37.6. The patient was started on a heparin drip in the ED and received 750 mg IV Levaquin and 1 L IV normal saline. The patient was seen and examined at the bedside in the ED.  The patient is not oriented x4 per his baseline; however, he is able to answer some questions appropriately. I did have a discussion with the patient and the patient's wife over the phone in regards to his code status.  The patient does have a DNR/DNI with comfort measures only. The patient's wife states that he does not want any procedures done at all as these are his wishes. The patient is being admitted to the hospital for management of COVID-19 pneumonia, NSTEMI, Rule out PE, and dehydration. 1/31/22: Patient is a 76-year-old male history of chronic hypoxic respiratory failure on home oxygen 3 L at baseline admitted to hospital for acute hypoxic respiratory failure due to COVID-19 pneumonia patient was treated with supplemental oxygen, antibiotics and Decadron, hospitalization was complicated by acute kidney injury on CKD and elevated troponin, as time progressed patient improved with medical treatment, patient was evaluated by Cardiology, recommended medical therapy.  Patient will be discharged.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Prohormone brain natriuretic peptide increased, SARS-CoV-2 test positive, Troponin increased, White blood cell count increased
Clinical narrative: Moderna Dose 1 4/27/21 (008C21A); Moderna Dose 2 5/25/21 (024C21A); COVID Positive 1/26/22; 1/26/22: Patient is a 76-year-old male with a past medical history significant for type 2 diabetes with diabetic neuropathy, coronary artery disease, hypertension, peripheral vascular disease, CKD, history of tracheostomy. The patient presents to the ED today via EMS with new onset confusion that began this afternoon. The patient's accompanying symptoms include shortness of breath, and cough.  He denies any chest pain, nausea, vomiting, diarrhea or abdominal pain. The patient tested positive for COVID-19 yesterday at the facility.  The patient was on 3 L oxygen via nasal cannula with O2 saturations at 75% prior to arrival to ED.  since arrival patient's O2 saturations have improved to 92% on 2 L oxygen via nasal cannula.  The patient is vaccinated against COVID-19 and has received is booster vaccination as well. The patient's symptoms began 2 days ago and have worsened rapidly according to the nursing home.  He has not been taking any medications for relief of his symptoms.  The patient denies any alcohol abuse, illicit drug abuse or tobacco use. Upon arrival to ED patient's temperature is 99.3°, heart rate 106, respirations 20, pulse ox 99% on 2 L oxygen via nasal cannula, blood pressure 123/100. Patient's laboratory findings are significant for sodium 132, chloride 95, glucose 184, BUN 63, creatinine 2.73, proBNP 21134, troponin 4.22, WBC 11.81, hemoglobin 11.2, hematocrit 37.6. The patient was started on a heparin drip in the ED and received 750 mg IV Levaquin and 1 L IV normal saline. The patient was seen and examined at the bedside in the ED.  The patient is not oriented x4 per his baseline; however, he is able to answer some questions appropriately. I did have a discussion with the patient and the patient's wife over the phone in regards to his code status.  The patient does have a DNR/DNI with comfort measures only. The patient's wife states that he does not want any procedures done at all as these are his wishes. The patient is being admitted to the hospital for management of COVID-19 pneumonia, NSTEMI, Rule out PE, and dehydration. 1/31/22: Patient is a 76-year-old male history of chronic hypoxic respiratory failure on home oxygen 3 L at baseline admitted to hospital for acute hypoxic respiratory failure due to COVID-19 pneumonia patient was treated with supplemental oxygen, antibiotics and Decadron, hospitalization was complicated by acute kidney injury on CKD and elevated troponin, as time progressed patient improved with medical treatment, patient was evaluated by Cardiology, recommended medical therapy.  Patient will be discharged.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer > 2 weeks
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer >2 weeks
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram abnormal, Blood test normal, Immunisation reaction, Magnetic resonance imaging normal, Tinnitus
Clinical narrative: Ringing in the ears,the  left first followed by the right several months later, approxiamtely 30 days after receiving the booster shot.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administered past beyond use date
Age: 47.0
Sex: M
Vaccine: FLUR4
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient was registered for a Covid 19 vaccine. Flublok was inadvertently administered. He did not experience any adverse effects.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Dyspnoea, Fatigue, Hypoxia
Clinical narrative: Pt had a positive COVID test on 12/27/21 from; 1/11/22 positive COVID test from Hospital 2/2/22 and 2/22/22 had positive COVID tests from Medical Center; 4/8/22 admitted to Hospital with fever, fatigue, SOB; dx with pneumonia secondary to pneumocystis; given ABX; hypoxic; noninvasive ventilation; DNR; inpatient hospice where pt passed away..
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Mechanical ventilation, Pneumocystis jirovecii pneumonia, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Pt had a positive COVID test on 12/27/21 from; 1/11/22 positive COVID test from Hospital 2/2/22 and 2/22/22 had positive COVID tests from Medical Center; 4/8/22 admitted to Hospital with fever, fatigue, SOB; dx with pneumonia secondary to pneumocystis; given ABX; hypoxic; noninvasive ventilation; DNR; inpatient hospice where pt passed away..
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administered past beyond use date
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site warmth
Clinical narrative: had rash and heat in the arm of the vaccine given location
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Dizziness, Hypertension, Hypoaesthesia, Vertigo
Clinical narrative: 10 MINS AFTER VACCINE PT FELT DIZZY, LIGHT HEADED, VERTIGO, ABDOMINAL PAIN, LEG NUMBNESS, HTN, CALLED 911, EMS ADVISED HOSPITAL
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Cough, Dyspnoea, Exposure during pregnancy, Full blood count
Clinical narrative: Participant presented with chronic episodic cough the most recent having lasted since 14 Apr 2022 before admission. The Participant is a 33-year-old Female G6 P5+0 who at the time of hospitalisation or admission on 16 Jun 2022 was diagnosed with severe pneumonia in pregnancy. The participant reported a history of chronic intermittent productive cough the cough was first picked during surveillance on 14 Apr 2022 However during her hospitalization there were discrepant durations of this cough documented. There was no associated fever or other symptoms like weight loss or night sweats however the participant had chest pain and difficulty in breathing and or fast breathing. She is vaccinated with 2 doses of Moderna vaccine. first dose was on 21 Feb 2022, the second dose was received on 21 Mar 2022. Her baseline viral load at study entry on 21 Feb 2022 was 777 cp/ml. Remarkable findings at admission were respiratory findings of Tachypnoea 25 breaths per minute, supraclavicular recession, and coarse crepitations right mammary area. Other complaints during this hospitalization included a whitish Per vaginal discharge with urgency and frequency. Past obstetric history was unremarkable with all 5 deliveries by Spontaneous vertex delivery. Past medical and surgical history was unremarkable apart from being a youth perinatally infected with HIV, stable on her current treatment. No past Tuberculosis diagnosis or treatment. The Participant remained saturated at 95-96%. However, the participant was tachypneic at a rate of 32-34, BPs remained between 110/60 to 98/60 while admitted. Obstetric examination: fundal height was 24/40 weeks. Other systems examined were within normal limits. EDD BY LNMP:05 OCT  2022,BY ULTRASOUND 06 OCT 2022. Diagnosis with differentials at admission was severe pneumonia ruling out possible:- ? Pulmonary tuberculosis,  ? COVID -19, ? Pneumocystis Jiroveci Pneumonia, ? Pleural Effusion.   Medication received during hospitalisation is:- I.V ceftriaxone 1 g o.d then 2g o.d, Tabs fefol 1-tab o.d tabs cotrimoxazole 960mg o.d ART Tenofovir disoproxil fumarate/lamivudine/dolutegravir 1 tablet o.d
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Mycobacterium tuberculosis complex test negative, Pneumonia, Productive cough, SARS-CoV-2 test negative
Clinical narrative: Participant presented with chronic episodic cough the most recent having lasted since 14 Apr 2022 before admission. The Participant is a 33-year-old Female G6 P5+0 who at the time of hospitalisation or admission on 16 Jun 2022 was diagnosed with severe pneumonia in pregnancy. The participant reported a history of chronic intermittent productive cough the cough was first picked during surveillance on 14 Apr 2022 However during her hospitalization there were discrepant durations of this cough documented. There was no associated fever or other symptoms like weight loss or night sweats however the participant had chest pain and difficulty in breathing and or fast breathing. She is vaccinated with 2 doses of Moderna vaccine. first dose was on 21 Feb 2022, the second dose was received on 21 Mar 2022. Her baseline viral load at study entry on 21 Feb 2022 was 777 cp/ml. Remarkable findings at admission were respiratory findings of Tachypnoea 25 breaths per minute, supraclavicular recession, and coarse crepitations right mammary area. Other complaints during this hospitalization included a whitish Per vaginal discharge with urgency and frequency. Past obstetric history was unremarkable with all 5 deliveries by Spontaneous vertex delivery. Past medical and surgical history was unremarkable apart from being a youth perinatally infected with HIV, stable on her current treatment. No past Tuberculosis diagnosis or treatment. The Participant remained saturated at 95-96%. However, the participant was tachypneic at a rate of 32-34, BPs remained between 110/60 to 98/60 while admitted. Obstetric examination: fundal height was 24/40 weeks. Other systems examined were within normal limits. EDD BY LNMP:05 OCT  2022,BY ULTRASOUND 06 OCT 2022. Diagnosis with differentials at admission was severe pneumonia ruling out possible:- ? Pulmonary tuberculosis,  ? COVID -19, ? Pneumocystis Jiroveci Pneumonia, ? Pleural Effusion.   Medication received during hospitalisation is:- I.V ceftriaxone 1 g o.d then 2g o.d, Tabs fefol 1-tab o.d tabs cotrimoxazole 960mg o.d ART Tenofovir disoproxil fumarate/lamivudine/dolutegravir 1 tablet o.d
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Sputum normal, Tachypnoea, Ultrasound scan normal, Urine analysis, Vaginal discharge
Clinical narrative: Participant presented with chronic episodic cough the most recent having lasted since 14 Apr 2022 before admission. The Participant is a 33-year-old Female G6 P5+0 who at the time of hospitalisation or admission on 16 Jun 2022 was diagnosed with severe pneumonia in pregnancy. The participant reported a history of chronic intermittent productive cough the cough was first picked during surveillance on 14 Apr 2022 However during her hospitalization there were discrepant durations of this cough documented. There was no associated fever or other symptoms like weight loss or night sweats however the participant had chest pain and difficulty in breathing and or fast breathing. She is vaccinated with 2 doses of Moderna vaccine. first dose was on 21 Feb 2022, the second dose was received on 21 Mar 2022. Her baseline viral load at study entry on 21 Feb 2022 was 777 cp/ml. Remarkable findings at admission were respiratory findings of Tachypnoea 25 breaths per minute, supraclavicular recession, and coarse crepitations right mammary area. Other complaints during this hospitalization included a whitish Per vaginal discharge with urgency and frequency. Past obstetric history was unremarkable with all 5 deliveries by Spontaneous vertex delivery. Past medical and surgical history was unremarkable apart from being a youth perinatally infected with HIV, stable on her current treatment. No past Tuberculosis diagnosis or treatment. The Participant remained saturated at 95-96%. However, the participant was tachypneic at a rate of 32-34, BPs remained between 110/60 to 98/60 while admitted. Obstetric examination: fundal height was 24/40 weeks. Other systems examined were within normal limits. EDD BY LNMP:05 OCT  2022,BY ULTRASOUND 06 OCT 2022. Diagnosis with differentials at admission was severe pneumonia ruling out possible:- ? Pulmonary tuberculosis,  ? COVID -19, ? Pneumocystis Jiroveci Pneumonia, ? Pleural Effusion.   Medication received during hospitalisation is:- I.V ceftriaxone 1 g o.d then 2g o.d, Tabs fefol 1-tab o.d tabs cotrimoxazole 960mg o.d ART Tenofovir disoproxil fumarate/lamivudine/dolutegravir 1 tablet o.d
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cells urine positive
Clinical narrative: Participant presented with chronic episodic cough the most recent having lasted since 14 Apr 2022 before admission. The Participant is a 33-year-old Female G6 P5+0 who at the time of hospitalisation or admission on 16 Jun 2022 was diagnosed with severe pneumonia in pregnancy. The participant reported a history of chronic intermittent productive cough the cough was first picked during surveillance on 14 Apr 2022 However during her hospitalization there were discrepant durations of this cough documented. There was no associated fever or other symptoms like weight loss or night sweats however the participant had chest pain and difficulty in breathing and or fast breathing. She is vaccinated with 2 doses of Moderna vaccine. first dose was on 21 Feb 2022, the second dose was received on 21 Mar 2022. Her baseline viral load at study entry on 21 Feb 2022 was 777 cp/ml. Remarkable findings at admission were respiratory findings of Tachypnoea 25 breaths per minute, supraclavicular recession, and coarse crepitations right mammary area. Other complaints during this hospitalization included a whitish Per vaginal discharge with urgency and frequency. Past obstetric history was unremarkable with all 5 deliveries by Spontaneous vertex delivery. Past medical and surgical history was unremarkable apart from being a youth perinatally infected with HIV, stable on her current treatment. No past Tuberculosis diagnosis or treatment. The Participant remained saturated at 95-96%. However, the participant was tachypneic at a rate of 32-34, BPs remained between 110/60 to 98/60 while admitted. Obstetric examination: fundal height was 24/40 weeks. Other systems examined were within normal limits. EDD BY LNMP:05 OCT  2022,BY ULTRASOUND 06 OCT 2022. Diagnosis with differentials at admission was severe pneumonia ruling out possible:- ? Pulmonary tuberculosis,  ? COVID -19, ? Pneumocystis Jiroveci Pneumonia, ? Pleural Effusion.   Medication received during hospitalisation is:- I.V ceftriaxone 1 g o.d then 2g o.d, Tabs fefol 1-tab o.d tabs cotrimoxazole 960mg o.d ART Tenofovir disoproxil fumarate/lamivudine/dolutegravir 1 tablet o.d
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administered past beyond use date
Age: 56.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Malaise, Pyrexia
Clinical narrative: Headache, fever, malaise began evening after getting the vaccine and more notable the next morning.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles, presentation of face, neck with multiple dermatomes involved
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Bacterial infection, COVID-19, Cardio-respiratory arrest
Clinical narrative: PFIZER COVID #3 VACCINE GIVEN 8/23/21, LOT # FC3184; pt admitted to hospital on 2/7/22 and dx with AHRF secondary to multilobe pneumonia from COVID virus, bacterial infection, PE; Airvos at 90% support; ABX, remdesivir, steroids, heparin drip, Vitamins C, D and zince; multiorgan failure; suffered cardiopulmonary arrest with ACLS protocol followed; passed away in the hospital
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Multiple organ dysfunction syndrome, Pneumonia
Clinical narrative: PFIZER COVID #3 VACCINE GIVEN 8/23/21, LOT # FC3184; pt admitted to hospital on 2/7/22 and dx with AHRF secondary to multilobe pneumonia from COVID virus, bacterial infection, PE; Airvos at 90% support; ABX, remdesivir, steroids, heparin drip, Vitamins C, D and zince; multiorgan failure; suffered cardiopulmonary arrest with ACLS protocol followed; passed away in the hospital
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administered past beyond use date
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Arthralgia, Balance disorder, COVID-19
Clinical narrative: Pfizer Dose 1 3/18/21 (EN6207) Pfizer Dose 2 4/8/21 (EW0161) COVID Positive 1/8/22  1/8/22: 94 years old male patient who presented to the emergency department because of feeling off balance  Patient has a history in the documentation of being on anticoagulation with Eliquis however unclear reason. States that he has been feeling lightheaded, dizzy, associated with palpitations.  He did fall this morning and hit his head reportedly and reports neck pain and knee pain. Denies shortness of breath, hip pain, abdominal pain, chest pain. Patient lives at home with his wife who has been feeling ill with cold-like symptoms.  Patient denies ever losing consciousness, having incontinence of any kind.  CT head without contrast was negative for any acute abnormalities. He did undergo CT angio chest for PE which noted bilateral PE and findings concerning for pneumonia. He was febrile in the ED with Tmax at 100.9.  He was given Levaquin and started on heparin drip in the emergency department. Patient reports drinking alcohol daily, last drink of wine was yesterday  1/11/22:  A 94-year-old man who presented to the emergency room with complaints of feeling lightheaded.  He fell and hit his head on the morning of presentation.  In the emergency room, patient was febrile T-max of 100.9 degrees.  CT head revealed no abnormalities.  CT angio of the chest revealed bilateral pulmonary embolism and bilateral pneumonia.  COVID-19 screen resulted positive. Patient is on room air and not requiring oxygen. Echocardiogram done to rule out right heart strain was negative.  Patient was initiated on IV heparin infusion and transition to apixaban for anticoagulation therapy.  Was assessed by Physical therapy, recommendations for skilled nursing facility.  For COVID-19, patient is on room air with no oxygen requirement.  Patient is being discharged to skilled nursing facility in a stable condition.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram head normal, Dizziness, Echocardiogram normal, Fall, Head injury
Clinical narrative: Pfizer Dose 1 3/18/21 (EN6207) Pfizer Dose 2 4/8/21 (EW0161) COVID Positive 1/8/22  1/8/22: 94 years old male patient who presented to the emergency department because of feeling off balance  Patient has a history in the documentation of being on anticoagulation with Eliquis however unclear reason. States that he has been feeling lightheaded, dizzy, associated with palpitations.  He did fall this morning and hit his head reportedly and reports neck pain and knee pain. Denies shortness of breath, hip pain, abdominal pain, chest pain. Patient lives at home with his wife who has been feeling ill with cold-like symptoms.  Patient denies ever losing consciousness, having incontinence of any kind.  CT head without contrast was negative for any acute abnormalities. He did undergo CT angio chest for PE which noted bilateral PE and findings concerning for pneumonia. He was febrile in the ED with Tmax at 100.9.  He was given Levaquin and started on heparin drip in the emergency department. Patient reports drinking alcohol daily, last drink of wine was yesterday  1/11/22:  A 94-year-old man who presented to the emergency room with complaints of feeling lightheaded.  He fell and hit his head on the morning of presentation.  In the emergency room, patient was febrile T-max of 100.9 degrees.  CT head revealed no abnormalities.  CT angio of the chest revealed bilateral pulmonary embolism and bilateral pneumonia.  COVID-19 screen resulted positive. Patient is on room air and not requiring oxygen. Echocardiogram done to rule out right heart strain was negative.  Patient was initiated on IV heparin infusion and transition to apixaban for anticoagulation therapy.  Was assessed by Physical therapy, recommendations for skilled nursing facility.  For COVID-19, patient is on room air with no oxygen requirement.  Patient is being discharged to skilled nursing facility in a stable condition.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Palpitations, Pneumonia, Pulmonary embolism, Pyrexia
Clinical narrative: Pfizer Dose 1 3/18/21 (EN6207) Pfizer Dose 2 4/8/21 (EW0161) COVID Positive 1/8/22  1/8/22: 94 years old male patient who presented to the emergency department because of feeling off balance  Patient has a history in the documentation of being on anticoagulation with Eliquis however unclear reason. States that he has been feeling lightheaded, dizzy, associated with palpitations.  He did fall this morning and hit his head reportedly and reports neck pain and knee pain. Denies shortness of breath, hip pain, abdominal pain, chest pain. Patient lives at home with his wife who has been feeling ill with cold-like symptoms.  Patient denies ever losing consciousness, having incontinence of any kind.  CT head without contrast was negative for any acute abnormalities. He did undergo CT angio chest for PE which noted bilateral PE and findings concerning for pneumonia. He was febrile in the ED with Tmax at 100.9.  He was given Levaquin and started on heparin drip in the emergency department. Patient reports drinking alcohol daily, last drink of wine was yesterday  1/11/22:  A 94-year-old man who presented to the emergency room with complaints of feeling lightheaded.  He fell and hit his head on the morning of presentation.  In the emergency room, patient was febrile T-max of 100.9 degrees.  CT head revealed no abnormalities.  CT angio of the chest revealed bilateral pulmonary embolism and bilateral pneumonia.  COVID-19 screen resulted positive. Patient is on room air and not requiring oxygen. Echocardiogram done to rule out right heart strain was negative.  Patient was initiated on IV heparin infusion and transition to apixaban for anticoagulation therapy.  Was assessed by Physical therapy, recommendations for skilled nursing facility.  For COVID-19, patient is on room air with no oxygen requirement.  Patient is being discharged to skilled nursing facility in a stable condition.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sick relative
Clinical narrative: Pfizer Dose 1 3/18/21 (EN6207) Pfizer Dose 2 4/8/21 (EW0161) COVID Positive 1/8/22  1/8/22: 94 years old male patient who presented to the emergency department because of feeling off balance  Patient has a history in the documentation of being on anticoagulation with Eliquis however unclear reason. States that he has been feeling lightheaded, dizzy, associated with palpitations.  He did fall this morning and hit his head reportedly and reports neck pain and knee pain. Denies shortness of breath, hip pain, abdominal pain, chest pain. Patient lives at home with his wife who has been feeling ill with cold-like symptoms.  Patient denies ever losing consciousness, having incontinence of any kind.  CT head without contrast was negative for any acute abnormalities. He did undergo CT angio chest for PE which noted bilateral PE and findings concerning for pneumonia. He was febrile in the ED with Tmax at 100.9.  He was given Levaquin and started on heparin drip in the emergency department. Patient reports drinking alcohol daily, last drink of wine was yesterday  1/11/22:  A 94-year-old man who presented to the emergency room with complaints of feeling lightheaded.  He fell and hit his head on the morning of presentation.  In the emergency room, patient was febrile T-max of 100.9 degrees.  CT head revealed no abnormalities.  CT angio of the chest revealed bilateral pulmonary embolism and bilateral pneumonia.  COVID-19 screen resulted positive. Patient is on room air and not requiring oxygen. Echocardiogram done to rule out right heart strain was negative.  Patient was initiated on IV heparin infusion and transition to apixaban for anticoagulation therapy.  Was assessed by Physical therapy, recommendations for skilled nursing facility.  For COVID-19, patient is on room air with no oxygen requirement.  Patient is being discharged to skilled nursing facility in a stable condition.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: The vaccine the patient was given expired on 6/17/22, but was given on 6/21/22. Patient has not report any adverse events
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Atelectasis, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Fall
Clinical narrative: Patient received moderna vaccine on 3/18/21, 4/15/21 and pfizer vaccine on 12/23/21. Presented to ER on 6/11/22. Admitted due to fall. COVID test not done until 6/13/22 which was found to be COVID positive. She had mild hypoxia, which may be related to CHF as she was receiving fluids for rhabdomyolysis.  She was started on remdesivir, steroids, she was also treated for community-acquired pneumonia. On room air starting 6/18/22 so remdesivir was stopped. Patient was discharged on 6/21/22
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Hiatus hernia, Hypoxia, Lung opacity, Pleural effusion, Pneumonia
Clinical narrative: Patient received moderna vaccine on 3/18/21, 4/15/21 and pfizer vaccine on 12/23/21. Presented to ER on 6/11/22. Admitted due to fall. COVID test not done until 6/13/22 which was found to be COVID positive. She had mild hypoxia, which may be related to CHF as she was receiving fluids for rhabdomyolysis.  She was started on remdesivir, steroids, she was also treated for community-acquired pneumonia. On room air starting 6/18/22 so remdesivir was stopped. Patient was discharged on 6/21/22
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Rhabdomyolysis, SARS-CoV-2 test positive
Clinical narrative: Patient received moderna vaccine on 3/18/21, 4/15/21 and pfizer vaccine on 12/23/21. Presented to ER on 6/11/22. Admitted due to fall. COVID test not done until 6/13/22 which was found to be COVID positive. She had mild hypoxia, which may be related to CHF as she was receiving fluids for rhabdomyolysis.  She was started on remdesivir, steroids, she was also treated for community-acquired pneumonia. On room air starting 6/18/22 so remdesivir was stopped. Patient was discharged on 6/21/22
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administered past beyond use date
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, C-reactive protein increased, COVID-19, Cough
Clinical narrative: Moderna Dose 1 4/5/21 (006B21A); Moderna Dose 2 5/3/21 (036B21A); COVID Positive 1/3/22; 1/3/22: A 73-year-old male with past medical of type 2 DM with neuropathy, hypertension and Parkinson's disease comes to ED following an episode of fall.  Complains of falling on the floor this morning, on was lying on the floor for a few hours.  Denies pain in the hip are back.  Has cough, mostly nonproductive.  Denies chest pain or shortness of breath or fever or chills.  Patient is vaccinated against COVID-19, has not had booster.  Denies sick contacts. In the ED he was febrile, vital signs stable and pulse ox 92% on room air.  CT angio chest showed multifocal pneumonia, D-dimer was elevated.  Acute PE ruled out. 1/11/22: Patient is admitted to the hospital, started on IV hydration and pulse ox is monitored.  Patient had hypoxia, was started on IV remdesivir and IV dexamethasone.  Has his oxygen requirements were trending up with the elevated CRP and elevated D-dimer, pulmonology consult was requested and the patient was started on Baricitinib.  He was also started on therapeutic anticoagulation with Lovenox 1 milligram/kg subcu q.12 hours as his D-dimer was greater than 4.0.  CT angio chest is negative for PE.  As the patient's medical condition gradually improved, oxygen has been weaned down.  Inflammatory markers were monitored, CRP and D-dimer trended down towards normal.  Lovenox is changed to 40 mg subcutaneous q.12 hours.  Patient did have mild troponin elevation without chest pain or EKG changes which is most likely secondary to tachycardia.  He is started on aspirin and the metoprolol.  His cultures have been negative.  Patient is also diuresed with the low-dose Lasix 20 mg p.o. daily.  Patient has been medically stable. Oxygen walk test is done, patient qualifies for home O2 2 L oxygen at rest and 4 L oxygen with exertion.  Findings are discussed with the patient, he is agreeable to have home oxygen.  Care coordination has assisted in delivering oxygen cylinders at home, both stationary and portable as patient is mobile.  Patient does have myotonic dystrophy, does not ambulate much around, uses walker and braces for ambulation.  Pulmonology has cleared him for discharge with the above oxygen settings and recommended follow-up with Dr. in 1 week via tele health.  PT, OT evaluation is done, patient is discharged home with visiting nurse services.  Discharge plan is discussed with the patient.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Culture negative, Electrocardiogram normal, Fall, Fibrin D dimer increased, Gait disturbance
Clinical narrative: Moderna Dose 1 4/5/21 (006B21A); Moderna Dose 2 5/3/21 (036B21A); COVID Positive 1/3/22; 1/3/22: A 73-year-old male with past medical of type 2 DM with neuropathy, hypertension and Parkinson's disease comes to ED following an episode of fall.  Complains of falling on the floor this morning, on was lying on the floor for a few hours.  Denies pain in the hip are back.  Has cough, mostly nonproductive.  Denies chest pain or shortness of breath or fever or chills.  Patient is vaccinated against COVID-19, has not had booster.  Denies sick contacts. In the ED he was febrile, vital signs stable and pulse ox 92% on room air.  CT angio chest showed multifocal pneumonia, D-dimer was elevated.  Acute PE ruled out. 1/11/22: Patient is admitted to the hospital, started on IV hydration and pulse ox is monitored.  Patient had hypoxia, was started on IV remdesivir and IV dexamethasone.  Has his oxygen requirements were trending up with the elevated CRP and elevated D-dimer, pulmonology consult was requested and the patient was started on Baricitinib.  He was also started on therapeutic anticoagulation with Lovenox 1 milligram/kg subcu q.12 hours as his D-dimer was greater than 4.0.  CT angio chest is negative for PE.  As the patient's medical condition gradually improved, oxygen has been weaned down.  Inflammatory markers were monitored, CRP and D-dimer trended down towards normal.  Lovenox is changed to 40 mg subcutaneous q.12 hours.  Patient did have mild troponin elevation without chest pain or EKG changes which is most likely secondary to tachycardia.  He is started on aspirin and the metoprolol.  His cultures have been negative.  Patient is also diuresed with the low-dose Lasix 20 mg p.o. daily.  Patient has been medically stable. Oxygen walk test is done, patient qualifies for home O2 2 L oxygen at rest and 4 L oxygen with exertion.  Findings are discussed with the patient, he is agreeable to have home oxygen.  Care coordination has assisted in delivering oxygen cylinders at home, both stationary and portable as patient is mobile.  Patient does have myotonic dystrophy, does not ambulate much around, uses walker and braces for ambulation.  Pulmonology has cleared him for discharge with the above oxygen settings and recommended follow-up with Dr. in 1 week via tele health.  PT, OT evaluation is done, patient is discharged home with visiting nurse services.  Discharge plan is discussed with the patient.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Inflammatory marker test, Myotonic dystrophy, Orthosis user, Pneumonia
Clinical narrative: Moderna Dose 1 4/5/21 (006B21A); Moderna Dose 2 5/3/21 (036B21A); COVID Positive 1/3/22; 1/3/22: A 73-year-old male with past medical of type 2 DM with neuropathy, hypertension and Parkinson's disease comes to ED following an episode of fall.  Complains of falling on the floor this morning, on was lying on the floor for a few hours.  Denies pain in the hip are back.  Has cough, mostly nonproductive.  Denies chest pain or shortness of breath or fever or chills.  Patient is vaccinated against COVID-19, has not had booster.  Denies sick contacts. In the ED he was febrile, vital signs stable and pulse ox 92% on room air.  CT angio chest showed multifocal pneumonia, D-dimer was elevated.  Acute PE ruled out. 1/11/22: Patient is admitted to the hospital, started on IV hydration and pulse ox is monitored.  Patient had hypoxia, was started on IV remdesivir and IV dexamethasone.  Has his oxygen requirements were trending up with the elevated CRP and elevated D-dimer, pulmonology consult was requested and the patient was started on Baricitinib.  He was also started on therapeutic anticoagulation with Lovenox 1 milligram/kg subcu q.12 hours as his D-dimer was greater than 4.0.  CT angio chest is negative for PE.  As the patient's medical condition gradually improved, oxygen has been weaned down.  Inflammatory markers were monitored, CRP and D-dimer trended down towards normal.  Lovenox is changed to 40 mg subcutaneous q.12 hours.  Patient did have mild troponin elevation without chest pain or EKG changes which is most likely secondary to tachycardia.  He is started on aspirin and the metoprolol.  His cultures have been negative.  Patient is also diuresed with the low-dose Lasix 20 mg p.o. daily.  Patient has been medically stable. Oxygen walk test is done, patient qualifies for home O2 2 L oxygen at rest and 4 L oxygen with exertion.  Findings are discussed with the patient, he is agreeable to have home oxygen.  Care coordination has assisted in delivering oxygen cylinders at home, both stationary and portable as patient is mobile.  Patient does have myotonic dystrophy, does not ambulate much around, uses walker and braces for ambulation.  Pulmonology has cleared him for discharge with the above oxygen settings and recommended follow-up with Dr. in 1 week via tele health.  PT, OT evaluation is done, patient is discharged home with visiting nurse services.  Discharge plan is discussed with the patient.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Polyuria, Tachycardia, Troponin increased, Walking aid user, Walking distance test abnormal
Clinical narrative: Moderna Dose 1 4/5/21 (006B21A); Moderna Dose 2 5/3/21 (036B21A); COVID Positive 1/3/22; 1/3/22: A 73-year-old male with past medical of type 2 DM with neuropathy, hypertension and Parkinson's disease comes to ED following an episode of fall.  Complains of falling on the floor this morning, on was lying on the floor for a few hours.  Denies pain in the hip are back.  Has cough, mostly nonproductive.  Denies chest pain or shortness of breath or fever or chills.  Patient is vaccinated against COVID-19, has not had booster.  Denies sick contacts. In the ED he was febrile, vital signs stable and pulse ox 92% on room air.  CT angio chest showed multifocal pneumonia, D-dimer was elevated.  Acute PE ruled out. 1/11/22: Patient is admitted to the hospital, started on IV hydration and pulse ox is monitored.  Patient had hypoxia, was started on IV remdesivir and IV dexamethasone.  Has his oxygen requirements were trending up with the elevated CRP and elevated D-dimer, pulmonology consult was requested and the patient was started on Baricitinib.  He was also started on therapeutic anticoagulation with Lovenox 1 milligram/kg subcu q.12 hours as his D-dimer was greater than 4.0.  CT angio chest is negative for PE.  As the patient's medical condition gradually improved, oxygen has been weaned down.  Inflammatory markers were monitored, CRP and D-dimer trended down towards normal.  Lovenox is changed to 40 mg subcutaneous q.12 hours.  Patient did have mild troponin elevation without chest pain or EKG changes which is most likely secondary to tachycardia.  He is started on aspirin and the metoprolol.  His cultures have been negative.  Patient is also diuresed with the low-dose Lasix 20 mg p.o. daily.  Patient has been medically stable. Oxygen walk test is done, patient qualifies for home O2 2 L oxygen at rest and 4 L oxygen with exertion.  Findings are discussed with the patient, he is agreeable to have home oxygen.  Care coordination has assisted in delivering oxygen cylinders at home, both stationary and portable as patient is mobile.  Patient does have myotonic dystrophy, does not ambulate much around, uses walker and braces for ambulation.  Pulmonology has cleared him for discharge with the above oxygen settings and recommended follow-up with Dr. in 1 week via tele health.  PT, OT evaluation is done, patient is discharged home with visiting nurse services.  Discharge plan is discussed with the patient.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Dizziness, SARS-CoV-2 test positive
Clinical narrative: Patient received moderna vaccine on 8/12/21 and 9/9/21. Presented to ER on 6/17/22 and found to be covid positive. presented to the emergency department complaining of weakness and dizziness.  She is living at home alone since her husband was placed in nursing home and having difficulties with self-care.  Workup in the emergency room sewed positivity for COVID so she was admitted.  Supportive care was initiated.  Found via workup to also have urinary tract infection.  Was started with physical therapy and occupational therapy and was felt she would benefit from continued rehab and nursing home setting.  Case Management consulted and this was facilitated.  Was discharged to local care Home on the above date in stable condition.  Was not short of breath or hypoxic during her hospitalization. Discharged on 6/21/22
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: Patient received moderna vaccine on 8/12/21 and 9/9/21. Presented to ER on 6/17/22 and found to be covid positive. presented to the emergency department complaining of weakness and dizziness.  She is living at home alone since her husband was placed in nursing home and having difficulties with self-care.  Workup in the emergency room sewed positivity for COVID so she was admitted.  Supportive care was initiated.  Found via workup to also have urinary tract infection.  Was started with physical therapy and occupational therapy and was felt she would benefit from continued rehab and nursing home setting.  Case Management consulted and this was facilitated.  Was discharged to local care Home on the above date in stable condition.  Was not short of breath or hypoxic during her hospitalization. Discharged on 6/21/22
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administered past beyond use date
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Product given to patient expired on 6/17/22, but was given on 6/22/22. Patient has reported no adverse reaction.